RxDoctor Payments Data

Lenhanh Tran, MD

Otolaryngology · Las Vegas, NVNPI 1801840376

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations.

$3,271in general payments, 2019–2025

Across 106 payments — averaging $30.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$665
  • Intersect ENT, Inc.$622
  • Cochlear Americas$569
  • GSK$528
  • Advanced Bionics, LLC$162
  • Acclarent, Inc$161
  • plus $564 from 6 others

What the payments were for

  • Food & beverage$3,25399%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,271 in reported general payments places this provider in the 60th percentile of 41 otolaryngology providers in Nevada.

See all otolaryngology providers in Nevada

Medicare billing

Part B allowed, 2024
$42,371
Medicare patients
129
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate77$1,766
Montelukast Sodium32$898
Ipratropium Bromide14$579
Azelastine Hcl13$331
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$257
Mupirocin35$207
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$52

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →